Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology
Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂), a compound preparation that consists of 5 traditional Chinese medicines: Herba Asari , Rhizoma Alpiniae Officinarum, Lig...
Gespeichert in:
| Veröffentlicht in: | Chinese journal of integrative medicine 2021-06, Vol.27 (6), p.470-480 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 480 |
|---|---|
| container_issue | 6 |
| container_start_page | 470 |
| container_title | Chinese journal of integrative medicine |
| container_volume | 27 |
| creator | Zhang, Yu-zhuo Zeng, Rui-xiang Zhou, Yuan-shen Zhang, Min-zhou |
| description | Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂), a compound preparation that consists of 5 traditional Chinese medicines:
Herba Asari , Rhizoma Alpiniae Officinarum, Lignum Santali Albi, Fructus Piperis Longi
, and
Borneolum
, has been used in the treatment of AP for many years, exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol, this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition, clinical research, animal experiments, and network pharmacology prediction. Meanwhile, we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP. |
| doi_str_mv | 10.1007/s11655-021-2867-y |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2534615038</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2534615038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c321t-1c8ec8737242987996ae6c48faac71dad2e72123bf41251fc91cc6a6f772dedf3</originalsourceid><addsrcrecordid>eNp9kL1OwzAUhSMEElB4ADaPMAR8ncRO2CrEn6gAIZgt49yUQGq3dkLpChM7G--AGFngbYrgLQgqM9M9w_mOdL8gWAO6CZSKLQ_AkySkDEKWchFO5oIlyLIopDFl823mgrUZksVg2ftrShPBabIUjI4aZe5Ka_qki856W5H16cv718Pb5-vT9_PH9PF-g5SGnDtU9QBNTWxBuqZfGkVOUdfWlX6bdEmvrNGpunFIzvC2xDFRJifHWI-tuyGnV8oNlLaV7U9WgoVCVR5X_24nuNjbPd85CHsn-4c73V6oIwZ1CDpFnYpIsJhlqcgyrpDrOC2U0gJylTMUDFh0WcTAEih0BlpzxQshWI55EXWC9dnu0NlRg76Wg9JrrCpl0DZesiSKOSQ0StsqzKq6NeAdFnLoyoFyEwlU_uqVM72y1St_9cpJy7AZ49uu6aOT17Zxpv3oH-gHAFiEEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2534615038</pqid></control><display><type>article</type><title>Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology</title><source>SpringerLink Journals</source><source>Alma/SFX Local Collection</source><creator>Zhang, Yu-zhuo ; Zeng, Rui-xiang ; Zhou, Yuan-shen ; Zhang, Min-zhou</creator><creatorcontrib>Zhang, Yu-zhuo ; Zeng, Rui-xiang ; Zhou, Yuan-shen ; Zhang, Min-zhou</creatorcontrib><description>Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂), a compound preparation that consists of 5 traditional Chinese medicines:
Herba Asari , Rhizoma Alpiniae Officinarum, Lignum Santali Albi, Fructus Piperis Longi
, and
Borneolum
, has been used in the treatment of AP for many years, exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol, this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition, clinical research, animal experiments, and network pharmacology prediction. Meanwhile, we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP.</description><identifier>ISSN: 1672-0415</identifier><identifier>EISSN: 1993-0402</identifier><identifier>DOI: 10.1007/s11655-021-2867-y</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Medicine ; Medicine & Public Health ; Review</subject><ispartof>Chinese journal of integrative medicine, 2021-06, Vol.27 (6), p.470-480</ispartof><rights>The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c321t-1c8ec8737242987996ae6c48faac71dad2e72123bf41251fc91cc6a6f772dedf3</citedby><cites>FETCH-LOGICAL-c321t-1c8ec8737242987996ae6c48faac71dad2e72123bf41251fc91cc6a6f772dedf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11655-021-2867-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11655-021-2867-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Zhang, Yu-zhuo</creatorcontrib><creatorcontrib>Zeng, Rui-xiang</creatorcontrib><creatorcontrib>Zhou, Yuan-shen</creatorcontrib><creatorcontrib>Zhang, Min-zhou</creatorcontrib><title>Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology</title><title>Chinese journal of integrative medicine</title><addtitle>Chin. J. Integr. Med</addtitle><description>Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂), a compound preparation that consists of 5 traditional Chinese medicines:
Herba Asari , Rhizoma Alpiniae Officinarum, Lignum Santali Albi, Fructus Piperis Longi
, and
Borneolum
, has been used in the treatment of AP for many years, exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol, this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition, clinical research, animal experiments, and network pharmacology prediction. Meanwhile, we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP.</description><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Review</subject><issn>1672-0415</issn><issn>1993-0402</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kL1OwzAUhSMEElB4ADaPMAR8ncRO2CrEn6gAIZgt49yUQGq3dkLpChM7G--AGFngbYrgLQgqM9M9w_mOdL8gWAO6CZSKLQ_AkySkDEKWchFO5oIlyLIopDFl823mgrUZksVg2ftrShPBabIUjI4aZe5Ka_qki856W5H16cv718Pb5-vT9_PH9PF-g5SGnDtU9QBNTWxBuqZfGkVOUdfWlX6bdEmvrNGpunFIzvC2xDFRJifHWI-tuyGnV8oNlLaV7U9WgoVCVR5X_24nuNjbPd85CHsn-4c73V6oIwZ1CDpFnYpIsJhlqcgyrpDrOC2U0gJylTMUDFh0WcTAEih0BlpzxQshWI55EXWC9dnu0NlRg76Wg9JrrCpl0DZesiSKOSQ0StsqzKq6NeAdFnLoyoFyEwlU_uqVM72y1St_9cpJy7AZ49uu6aOT17Zxpv3oH-gHAFiEEQ</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Zhang, Yu-zhuo</creator><creator>Zeng, Rui-xiang</creator><creator>Zhou, Yuan-shen</creator><creator>Zhang, Min-zhou</creator><general>Springer Singapore</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210601</creationdate><title>Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology</title><author>Zhang, Yu-zhuo ; Zeng, Rui-xiang ; Zhou, Yuan-shen ; Zhang, Min-zhou</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c321t-1c8ec8737242987996ae6c48faac71dad2e72123bf41251fc91cc6a6f772dedf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Yu-zhuo</creatorcontrib><creatorcontrib>Zeng, Rui-xiang</creatorcontrib><creatorcontrib>Zhou, Yuan-shen</creatorcontrib><creatorcontrib>Zhang, Min-zhou</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Chinese journal of integrative medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Yu-zhuo</au><au>Zeng, Rui-xiang</au><au>Zhou, Yuan-shen</au><au>Zhang, Min-zhou</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology</atitle><jtitle>Chinese journal of integrative medicine</jtitle><stitle>Chin. J. Integr. Med</stitle><date>2021-06-01</date><risdate>2021</risdate><volume>27</volume><issue>6</issue><spage>470</spage><epage>480</epage><pages>470-480</pages><issn>1672-0415</issn><eissn>1993-0402</eissn><abstract>Angina pectoris (AP) is the most common symptom of cardiovascular diseases, which seriously affects the quality of life in cardiovascular patients. Kuanxiong (KX) Aerosol (宽胸气雾剂), a compound preparation that consists of 5 traditional Chinese medicines:
Herba Asari , Rhizoma Alpiniae Officinarum, Lignum Santali Albi, Fructus Piperis Longi
, and
Borneolum
, has been used in the treatment of AP for many years, exhibiting a significant curative effect and less side-effect. For the convenience and comprehensive understanding of KX Aerosol, this review systematically summarizes evidence on KX Aerosol in the treatment of AP including the pharmacological effects of its composition, clinical research, animal experiments, and network pharmacology prediction. Meanwhile, we highlight the research limitation of KX Aerosol at present. This review may guide the clinical application of KX Aerosol and further provide a reference for the research of AP.</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><doi>10.1007/s11655-021-2867-y</doi><tpages>11</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1672-0415 |
| ispartof | Chinese journal of integrative medicine, 2021-06, Vol.27 (6), p.470-480 |
| issn | 1672-0415 1993-0402 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2534615038 |
| source | SpringerLink Journals; Alma/SFX Local Collection |
| subjects | Medicine Medicine & Public Health Review |
| title | Kuanxiong Aerosol (宽胸气雾剂) in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T05%3A24%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kuanxiong%20Aerosol%20(%E5%AE%BD%E8%83%B8%E6%B0%94%E9%9B%BE%E5%89%82)%20in%20Treatment%20of%20Angina%20Pectoris:%20A%20Literature%20Review%20and%20Network%20Pharmacology&rft.jtitle=Chinese%20journal%20of%20integrative%20medicine&rft.au=Zhang,%20Yu-zhuo&rft.date=2021-06-01&rft.volume=27&rft.issue=6&rft.spage=470&rft.epage=480&rft.pages=470-480&rft.issn=1672-0415&rft.eissn=1993-0402&rft_id=info:doi/10.1007/s11655-021-2867-y&rft_dat=%3Cproquest_cross%3E2534615038%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2534615038&rft_id=info:pmid/&rfr_iscdi=true |